PRAC1 and prostate carcinoma: Importantly, when the urine exosome PCA3/PRAC ratio was computed, we found that the PCA3/PRAC value in the prostate cancer group was significantly higher than that in the biopsy-negative group (Figure 1(e); p=0.006).